By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BeiGene Co.,Ltd 

No.30 Science Park Road
Zhong-Guan-Cun Life Science Park
Changping District  Beijing    China
Phone: n/a Fax: n/a



Company News
BeiGene Co.,Ltd Enrolls First Patient In Phase 1 Study Of BGB-290 7/7/2014 10:11:17 AM
BeiGene Co.,Ltd Receives $5 Million Clinical Milestone Payment For Development Of BGB-283 5/5/2014 9:46:16 AM
BeiGene Co.,Ltd Announces Addition Of Dr. Ronald Levy To Scientific Advisory Board 3/3/2014 7:31:56 AM
BeiGene Co.,Ltd Enrolls First Patient In Phase 1 Study Of BGB-283 12/19/2013 9:53:05 AM
Week in Review: BeiGene Co.,Ltd Out-Licenses Novel Cancer Drug to Merck Serono 11/18/2013 10:29:30 AM
BeiGene Co.,Ltd, Merck Serono Add $232 Million+ R&D Deal To Growing Cancer Partnership 11/13/2013 6:46:05 AM
BeiGene Co.,Ltd Signs Up Industry Veterans for Scientific Advisory Board 8/21/2013 8:59:44 AM
GENEWIZ, Inc. Announces Collaboration With BeiGene Co.,Ltd 7/31/2013 8:58:48 AM
BeiGene Co.,Ltd Licenses Ex-China Rights for Cancer Molecule to Merck Serono 5/31/2013 12:55:37 PM
BeiGene Co.,Ltd In-Licenses Two Potential Cancer Drugs from Janssen Pharmaceutica N.V. 10/14/2011 11:34:53 AM